137 related articles for article (PubMed ID: 1423846)
1. Expression of ras oncogene mRNA and protein in aberrant crypt foci.
Stopera SA; Bird RP
Carcinogenesis; 1992 Oct; 13(10):1863-8. PubMed ID: 1423846
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer.
Stopera SA; Murphy LC; Bird RP
Carcinogenesis; 1992 Nov; 13(11):2081-5. PubMed ID: 1423879
[TBL] [Abstract][Full Text] [Related]
3. Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer.
Stopera SA; Davie JR; Bird RP
Carcinogenesis; 1992 Apr; 13(4):573-8. PubMed ID: 1576709
[TBL] [Abstract][Full Text] [Related]
4. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
5. Effects of all-trans retinoic acid as a potential chemopreventive agent on the formation of azoxymethane-induced aberrant crypt foci: differential expression of c-myc and c-fos MRNA and protein.
Stopera SA; Bird RP
Int J Cancer; 1993 Mar; 53(5):798-803. PubMed ID: 8449605
[TBL] [Abstract][Full Text] [Related]
6. K-ras mutations in putative preneoplastic lesions in human colon.
Pretlow TP; Brasitus TA; Fulton NC; Cheyer C; Kaplan EL
J Natl Cancer Inst; 1993 Dec; 85(24):2004-7. PubMed ID: 8246286
[TBL] [Abstract][Full Text] [Related]
7. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
8. Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane.
Davies MJ; Rumsby PC
Teratog Carcinog Mutagen; 1998; 18(4):183-97. PubMed ID: 9804274
[TBL] [Abstract][Full Text] [Related]
9. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci.
Stopera SA; Bird RP
Cytobios; 1993; 73(293):73-88. PubMed ID: 8319499
[TBL] [Abstract][Full Text] [Related]
11. Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity.
Pretlow TP; Cheyer C; O'Riordan MA
Int J Cancer; 1994 Feb; 56(4):599-602. PubMed ID: 8112897
[TBL] [Abstract][Full Text] [Related]
12. Aberrant crypt foci of the colon as precursors of adenoma and cancer.
Takayama T; Katsuki S; Takahashi Y; Ohi M; Nojiri S; Sakamaki S; Kato J; Kogawa K; Miyake H; Niitsu Y
N Engl J Med; 1998 Oct; 339(18):1277-84. PubMed ID: 9791143
[TBL] [Abstract][Full Text] [Related]
13. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions.
Pretlow TP; O'Riordan MA; Pretlow TG; Stellato TA
J Cell Biochem Suppl; 1992; 16G():55-62. PubMed ID: 1361589
[TBL] [Abstract][Full Text] [Related]
14. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen.
Whiteley LO; Hudson L; Pretlow TP
Toxicol Pathol; 1996; 24(6):681-9. PubMed ID: 8994294
[TBL] [Abstract][Full Text] [Related]
15. K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients.
Shivapurkar N; Huang L; Ruggeri B; Swalsky PA; Bakker A; Finkelstein S; Frost A; Silverberg S
Cancer Lett; 1997 May; 115(1):39-46. PubMed ID: 9097977
[TBL] [Abstract][Full Text] [Related]
16. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
17. Aberrant crypts: putative preneoplastic foci in human colonic mucosa.
Pretlow TP; Barrow BJ; Ashton WS; O'Riordan MA; Pretlow TG; Jurcisek JA; Stellato TA
Cancer Res; 1991 Mar; 51(5):1564-7. PubMed ID: 1997197
[TBL] [Abstract][Full Text] [Related]
18. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability in aberrant crypt foci from human colons.
Heinen CD; Shivapurkar N; Tang Z; Groden J; Alabaster O
Cancer Res; 1996 Dec; 56(23):5339-41. PubMed ID: 8968080
[TBL] [Abstract][Full Text] [Related]
20. Colonic aberrant crypts may originate from impaired fissioning: relevance to increased risk of neoplasia.
Kristt D; Bryan K; Gal R
Hum Pathol; 1999 Dec; 30(12):1449-58. PubMed ID: 10667423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
